Strive Life is a dispensary model and
subsidiary brand of Item 9 Labs Corp, a publicly traded U.S.
cannabis company headquartered in Arizona.
GRAND FORKS, N.D., May 21, 2019 (GLOBE NEWSWIRE)
-- Item 9 Labs Corp. (INLB) (Item 9 Labs or
the Company), a leader in comfortable cannabis health solutions for
the modern consumer, today announced that medical marijuana
dispensary Strive Life Grand Forks, a partner following the
Companyâs Strive Life business model and brand, will officially
open on Wednesday, May 22nd, at 1809 13th
Avenue North, in Grand Forks, North Dakota.
The operation will offer a diverse inventory of
patient-focused products and will be open Tuesday through Friday,
10 a.m. â 7 p.m., and Saturday from 9 a.m. â 6 p.m.
Strive Life Grand Forks implements medical
marijuana dispensary best practices from across the United States
and globally. The dispensary model offered by Item 9 Labs features
thoughtfully designed environments for an elevated patient
âStrive Life will offer a diverse inventory of
quality products and quality medical cannabis solutions. We
received a warm welcome from the Grand Forks community at our soft
opening and now we are ready to serve North Dakota patients,â
stated Sara Gullickson, CEO of Item 9 Labs.
The invite-only family and friends event on May
17th offered a preview of the high-end retail space
before product was introduced. Local government officials and
community advocates were also in attendance.
âMy passion is people. I believe the most
satisfying moments in life come when I can help others and lend a
hand when itâs needed most. As trusted providers we look forward to
advancing the wellness of patients,â commented Strive Life Grand
Forks co-owner Jonathan OâKeefe.
In November 2018, Strive Life Grand Forks
received a permit to move forward with the medical marijuana
program to obtain a dispensary registration certificate. The
operation has a supply agreement with Pure Dakota, LLC, one of two
licensed manufacturers of usable medical cannabis in North
In addition to the Strive Life brand, Item 9 Labs
is operating as licensed dispensaries, cultivation, and
manufacturing facilities in multiple U.S. markets.
For information visit StriveGrandForks.com.
About Item 9 Labs Corp.:
Item 9 Labs Corp. (INLB)
creates comfortable cannabis health solutions for the modern
consumer. The Company is bringing best of industry practices to
markets from coast to coast through cultivation and production,
distinctive retail environments, licensing services, and diverse
product suites catering to different medical cannabis demographics.
Item 9 Labs Corp. is headquartered in Phoenix, Arizona, with
medical cannabis operations in multiple U.S. markets.
Item 9 Labs Corp.âs asset portfolio includes
Dispensary Permits, Dispensary Templates, and Strive Life. These
assets provide services specific to different stakeholder groups.
Dispensary Permits is the Companyâs consulting firm specializing in
strategic license application and compliance. Dispensary Templates,
a subdivision of the firm, is a technology platform with an
extensive digital library of licensing and business planning
resources. Strive Life is a turnkey dispensary model for the retail
sector, elevating the patient experience with consistent and
superior service, high-end design, and precision-tested products.
It is currently being implemented in Arizona and North Dakota.
In addition, Item 9 Labs Corp. is advancing the
industry with its dynamic product suites. The Company has created
complementary brands Item 9 Labs and Strive Wellness to channel
consumer diversity. Propriety delivery platforms include the Apollo
Vape and Pod system, as well as a pioneering intra-nasal device.
The Company has received multiple accolades for its medical-grade
flower and concentrates.
Item 9 Labs Corp. will be managing cultivation,
processing, distribution, and dispensary operations in up to ten
U.S. markets by the end of 2019. Current facilities include
distribution and processing operations Strive Wellness of Ohio and
Strive Wellness of Nevada, as well as dispensary Strive Life North
For more information, visit Item 9 Labs Corp.
Statement: This press release contains
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Such statements involve risks and uncertainties, including, but not
limited to, risks and effects of legal and administrative
proceedings and governmental regulation, especially in a foreign
country, future financial and operational results, competition,
general economic conditions, proposed transactions that are not
legally binding obligations of the company and the ability to
manage and continue growth. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual outcomes may vary materially from those
indicated. Important factors that could cause actual results to
differ materially from the forward-looking statements we make in
this news release include the introduction of new technology,
market conditions and those set forth in reports or documents we
file from time to time with the SEC. We undertake no obligation to
revise or update such statements to reflect current events or
circumstances after the date hereof or to reflect the occurrence of
Item 9 Labs Corp.